Regeneron · 5 hours ago
Senior Manager, Internal Medicine, Clinical Scientist (Cardio, Metabolic, & Renal)
Regeneron is a biopharmaceutical company that focuses on the development of innovative medicines. The Senior Manager, Internal Medicine, Clinical Scientist will lead the development and execution of clinical studies, ensuring the integrity and interpretation of study data in a cross-functional team environment.
BiopharmaBiotechnologyPharmaceutical
Responsibilities
Contributes to program team meetings, scientific advisory boards, study steering committees and data/safety monitoring meetings; participates in collaborative activities with other departments; Member of the Clinical Study Team and Global Clinical SubTeam
Develops/maintains understanding of therapeutic disease area(s) and drug candidate including underlying disease biology, clinical manifestations and therapeutic standard practice, compound(s) including mechanism of action and drug landscape
Applies basic scientific expertise to support initiation and execution of clinical research and development studies for early and/or late stage assets; Assists with development of the Expanded Synopsis and may author clinically relevant sections and review other scientific portions of clinical trial protocols and amendments
Assists with and may author/review documents related to trials, such as medical monitoring plans, SAPs, informed consents and clinical components of the Clinical Study Reports and may support the development of regulatory documents; may perform quality review
Maintains compliance in accordance with FDA, EMEA, ICH and GCP guidelines as well as applicable SOPs regarding clinical safety
Performs clinical/medical data review, including safety monitoring and activities and procedures that ensure patient safety
Collaborates with internal functions and external vendors to promote clinical study integrity
Exhibits strong analytical knowledge and skills to understand how study objectives and design impact data analysis; supports identification and/or identifies critical risks and mitigations
Promotes consistent first line medical/clinical data review techniques and conventions across assigned studies; Reviews clinical data review plan and medical monitoring plan for assigned studies
Qualification
Required
BS/MS/PhD/PharmD in a related field
≥ 8 years of pharmaceutical clinical drug development experience
Experience in one or more of the following therapeutic areas – cardiovascular, renal, metabolic disease
Demonstrated ability to influence within team and may influence cross functionally
Exhibit strong analytical and influencing skills; ability to communicate concise and clear messages, strong presentation skills
Independently uses professional concepts and company objectives to resolve complex issues in creative and effective ways
Strong management, interpersonal and problem-solving skills
Proven knowledge of the drug development process, Good Clinical Practice, study design, clinical research methodology & medical writing skills
Knowledge of clinical development process, regulatory requirements and ICH/GCP guidelines
Proven track in clinical trial process improvements
Considerable organizational awareness, including significant experience working cross-functionally
Benefits
Health and wellness programs (including medical, dental, vision, life, and disability insurance)
Fitness centers
401(k) company match
Family support benefits
Equity awards
Annual bonuses
Paid time off
Paid leaves (e.g., military and parental leave)
Company
Regeneron
Regeneron Pharmaceuticals specializes in the discovery, development, and commercialization of innovative medicines.
H1B Sponsorship
Regeneron has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (157)
2024 (128)
2023 (128)
2022 (137)
2021 (104)
2020 (122)
Funding
Current Stage
Public CompanyTotal Funding
$15.93MKey Investors
U.S. Department of Health & Human Services
2024-07-11Post Ipo Equity· $2.03M
2023-10-18Post Ipo Equity· $5M
2016-08-22Post Ipo Equity· $8.9M
Leadership Team
Recent News
Pharmaceutical Technology
2026-01-16
2026-01-16
Company data provided by crunchbase